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Objective: The study sought to assess the extent to which healthcare workers (HCWs)
adhere to the National Tuberculosis Program (NTP) guidelines for the diagnosis of smear
negative tuberculosis in Nigeria.
Method: This was a cross-sectional retrospective desk analysis of case files of 280 smear
negative pulmonary TB in six States in southern Nigeria.
Results: About 93% of the 280 patients had their first set of sputum smear microscopy tests
done, but only 3.6% had the second set of diagnostic tests as prescribed by the NTP guide-
lines. Only 45.7% (128/280) received broad spectrum antibiotics after their first smear
microscopy. 98% had a chest X-ray done, while 93.6% (262/280) had HIV counseling and
testing (HCT), out of which 45.0% were HIV positive. Overall, only 2 patients (0.7%) were
diagnosed in strict compliance with the NTP guidelines. Therewas no significant difference
in the pattern of diagnosis of smear negative TB cases and smear positive TB cases.
Conclusion: The adherence of HCWs to the NTP guidelines for diagnosis of smear negative
TB is apparently sub-optimal and needs improvement.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction
Sub-Saharan Africa, including Nigeria, has witnessed a signif-
icant increase in the incidence of tuberculosis (TB) in the past
few decades attributed to the increasing prevalence of HIV.
The trend shows a disproportionate increase in smear
negative cases relative to smear positive pulmonary TB. The
diagnosis of smear negative TB in resource-poor settings isassociated with significant difficulties, especially in HIV-
infected patients [1–5]. This is believed to be a consequence
of the following: the association between decreased host
immunity and reduced sputum-smear positivity; difficulty in
excluding other HIV-related diseases when making a
diagnosis of smear-negative PTB; and an increase in
false-negative sputum smears because of overstretched
resources [6].
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the diagnosis of sputum smear-negative pulmonary TB
should be based on the following criteria: at least 2 negative
sputum smears (including at least 1 early-morning speci-
men); chest radiography findings consistent with TB; and lack
of a response to a trial of broad-spectrum antimicrobial
agents. For such patients, if facilities are available, sputum
cultures should be obtained. In persons with known or sus-
pected HIV infection, the diagnostic evaluation should be
expedited [7]. Although non-response to the broad spectrum
antibiotics may suggest TB, a positive response does not
exclude it. The primary goal of an antibiotics trial is to treat
concomitant bacterial infections that are common both in
TB and non-TB patients [8].
In resource-constrained settings, the diagnosis of sputum
smear-negative pulmonary TB relies heavily on the clinicalCough of 2 weeks and more: c
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Fig. 1 – National algorithmjudgement of a medical officer, both in the interpretation of
the chest radiograph as well as the assessment of the
patient’s clinical status. Thus, making a diagnosis of smear-
negative pulmonary TB is more or less subjective depending
on the expertise of the physicians, particularly in settings
where sputum culture is not available.
Previous studies have highlighted the need for an accurate
and prompt diagnosis of smear negative pulmonary TB. Misdi-
agnosis of smear negative pulmonary TB often results in low
coverage of early treatment, increased transmission of the dis-
ease, increasedmorbidity and an untimely death. At the same
time, diagnosing or classifying individuals who do not have
the disease as smear positive patients also leads to wastage
of valuable resources, including time and materials [1].
Although operational research is necessary to determine
the most cost-effective approaches to the diagnosis andollect 3 specimens 
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could be obtained by implementing the effective measures
already available, such as improved adherence to diagnostic
and treatment guidelines. In recognition of these challenges
and the threat posed by the HIV epidemic, a number of coun-
tries have revised their protocol to accommodate these
developments.
In Nigeria, the algorithm for diagnosis of sputum smear
negative pulmonary TB is as shown below [9] (see Fig. 1).
The objectives of the algorithm are to ensure standardiza-
tion of diagnosis and reduce the delay in diagnosis, as well as
provide a basis for monitoring the quality of the National TB
Program (NTP). However, since adoption of the guidelines,
there has not been any systematic effort to validate them
for sensitivity and specificity and/or assess the level of com-
pliance by health workers in the field. This study is aimed
at ascertaining the degree of compliance to the NTP guide-
lines by health workers at the primary, secondary and tertiary
levels of the healthcare delivery system. The main issues
looked at include: the pattern of diagnosis of smear-negative
PTB and the degree to which clinicians actually followed the
criteria for diagnosing smear negative PTB in practice.
Methodology
The study was carried out in selected healthcare facilities
supported by the German Leprosy and Tuberculosis Relief
Association (GLRA) in six States in southern Nigeria. The
States include: Ebonyi and Enugu in the south-east geopoliti-
cal zone; Bayelsa and Rivers in the south-south zone; and Eki-
ti and Ogun in the south-west zone. From each State, the
healthcare facilities were selected purposively in the ratio of
2:6:2 for tertiary, secondary and primary healthcare facilities,
respectively. Case files of all sputum smear negative pulmon-
ary TB cases seen in the second quarter of 2010 (April to June)
were selected and reviewed using a questionnaire. The fol-
lowing data were collected: age, sex, sputum smear result
(1st and 2nd batches), CXR, HIV counseling and testing
(HCT), administration of antibiotics, date of commencement
of treatment following diagnosis, and whether the patient
was seen by a medical officer.
Data collected were entered and analyzed using SPSS ver-
sion 17. Findings were presented using relevant frequencyTable 1 – Socio-demographic characteristics of the patients.
Socio-demographic characteristics
of patients
N = 280 %
Age (in years)
5–14 6 2.1
15–24 22 7.9
25–34 104 37.1
35–44 53 18.9
45–54 35 12.5
55–64 36 12.9
65+ 24 8.4
Sex
Male 137 48.9
Female 143 51.1tables, and the test of association was carried out using chi-
square test. P-Value of 0.05 was assumed to be statistically
significant.
Limitation of the study
CXR findings were not included, and the basis of diagnosis of
smear-negative PTB was not specified.
Result
A total of 280 patient records were reviewed comprising 143
(51.1%) females and 137 (48.9%) males (see Table 1).
More than half of the patients studied (56.1%) were aged
between 25 and 44 years. One hundred and fifty patients
(54.2%) visited a secondary health care facility; the remainder
visited either a primary (23.6%) or tertiary (22.1%) healthcare
facility. The majority of them (92.5%) were attended to by a
medical doctor, and they included all but one of those who
visited a tertiary health facility, and 94.7 and 81.8% of those
who visited secondary or primary healthcare facilities,
respectively. About 93% of the subjects had a first set of spu-
tum smear diagnostic tests done, while only 3.6% of the
patients did the second set of sputum smear tests. One hun-
dred and twenty-eight (45.7%) of them received broad-spec-
trum antibiotics after the first set of sputum smear results
and were asked to return after completing treatment. About
90% of them had a chest radiograph done. HIV counseling
and testing (HCT) was offered to 262 (93.6%) patients, and a
total of 118 patients (45.0%) were HIV positive, while the
remainder (55.0%) were HIV negative.
Only two (0.7%) patients were diagnosed in total compli-
ance with the diagnostic criteria, which included two smear
negative results, two-week antibiotics trial, and a chest radio-
graph prior to commencing anti-TB therapy, as well as HCT
(see Table 2).
Some of the patients managed in secondary (4.6%) and ter-
tiary (19.3%) healthcare facilities were diagnosed without a
sputum smear result. A greater proportion (66.1%) of those
treated in the tertiary healthcare facilities was more likely
to have received broad-spectrum antibiotics. Most of those
who were not offered HCT were from the secondary health-
care facilities (11.2%); while about 20% and 10% of those seen
in the primary and secondary healthcare facilities respec-
tively had no chest radiograph. Although, primary healthcare
facilities (50.0%) reported the highest proportion of HIV posi-
tive cases, there was no significant difference in proportion of
HIV positive cases relative to the level of healthcare facilities
(X2 = 1.08, p = 0.583). The likelihood of having a chest radio-
graph done was associated with a higher level of healthcare
facility. Patients seen in the tertiary facilities were less likely
to have commenced treatment within 6 days of the first batch
of sputum results (X2 = 17.62, p = 0.007) (see Table 3).
There was no significant difference in pattern of manage-
ment of sputum-smear PTB between HIV positive and HIV
negative patients except for timing of commencement of
anti-TB therapy. Those who were commenced on treatment
at 14 weeks or more were more likely to be HIV positive
(X2 = 6.19; p = 0.045).
Table 2 – Pattern of management of smear-negative PTB at various levels of health facilities.
Diagnosis Level of healthcare facility
Total N = 280 (%) Primary
N = 66 (%)
Secondary
N = 152 (%)
Tertiary
N = 62(%)
Had 1st batch of sputum smear test done
Yes 261 (93.2) 66 (100) 145 (95.4) 50 (80.7)
No 19 (6.8) 0 (0.0) 7 (4.6) 12 (19.3)
Received broad spectrum antibiotics
Yes 128 (45.7) 17 (25.8) 70 (46.1) 41 (66.1)
No 84 (30.0) 29 (43.9) 54 (35.5) 1 (1.6)
DNK 68 (24.3) 20 (30.3) 28 (18.4) 20 (32.3)
Had 2nd batch of sputum smear test done
Yes 10 (3.6) 2 (3.0) 6 (3.9) 2 (3.2)
No 270 (96.4) 64 (97.0) 146 (96.1) 60 (96.8)
Had CXR done
Yes 251 (89.6) 53 (80.3) 138 (90.7) 60 (96.8)
No 29 (10.4) 13 (19.7) 14 (9.3) 2 (3.2)
Had HCT
Yes 262(93.5) 66(100.) 135 (88.8) 61 (98.4)
No 18 (6.5) 0 (0.0) 17 (11.2) 1 (1.6)
HIV serostatus (n = 262) N = 262(%) N = 66 (%) N = 135 (%) N = 61 (%)
Positive 118(45.0) 33 (50.0) 60 (44.4) 25 (41.0)
Negative 144(55.0) 33 (50.0) 75 (55.6) 36 (59.0)
Interval between first batch sputum and
commencement of treatment (in days) (n = 264)
N = 264(%) N = 66 (%) N = 148 (%) N = 50 (%)
0–6 173(65.5) 37 (56.1) 112 (75.7) 24 (48.0)
7–13 58 (22.0) 18 (27.3) 22 (14.9) 18 (36.0)
14–20 12 (4.6) 5 (7.6) 4 (2.7) 3 (6.0)
21+ 21 (7.9) 6 (9.1) 10 (6.8) 5 (10.0)
Table 3 – Pattern of management of Sputum-smear PTB in relation to HIV serostatus.
Diagnosis Level of healthcare facility X2 p-Value
Total
N = 262 (%)
HIV Positive
N = 118 (%)
HIV Negative
N = 144 (%)
Had 1st batch of sputum smear test done
Yes 244 (93.2) 110 (93.2) 134 (93.1) 0.00 0.958
No 18 (6.8) 8 (6.8) 10 (6.1)
Received broad spectrum antibiotics
Yes 123 (46.9) 55 (46.6) 68 (47.2)
No 75 (28.7) 28 (23.7) 47 (32.7) 4.21 0.121
DNK 64 (24.4) 35 (29.7) 29 (20.1)
Had 2nd batch of sputum smear test done
Yes 10 (3.8) 4 (3.4) 6 (4.2) 0.11 0.744
No 252 (96.2) 114 (96.6) 138 (95.8)
Had CXR done
Yes 235 (89.7) 107 (90.7) 128 (88.9)
No 27 (10.3) 11 (9.3) 16 (11.1) 0.22 0.635
Interval between first batch sputum result and
commencement of treatment (in days) (n = 247)
N = 247 (%) N = 110 (%) N = 137 (%)
0–6 160 (61.1) 74 (62.7) 86 (59.7)
7–13 54 (20.6) 17 (14.4) 37 (25.7) 6.19 0.045
14–20 12 (4.6) 10 (8.5) 2 (1.4) df = 2
21+ 21 (8.0) 9(7.6) 12 (8.3)
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Healthcare facilities for the management of TB in Nigeria cut
across all levels of healthcare. Although the secondary health-
care facilities accounted for most of the case load seen in this
study, in various States the level and type of health facility that
accounts for a greater proportion of case loads vary in accor-
dance with functionality and access. Until recently, there was
limited involvement of tertiary healthcare facilities in Directly
Observed Treatment Strategy (DOTS), which is the primary
strategy for TB control in the NTP. An increasing incidence of
sputum smear negative PTB in the country now provides the
basis for their greater involvement in the NTP. Patients who
visited primary healthcare facilities were less likely to be seen
by amedical officer becausemost primary healthcare facilities
in the country do not have medical officers.
The study revealed that sputum smear negative TB was
often diagnosedwithout compliancewith the national TB con-
trol program guideline/protocol. Reasons for non-compliance
were not identified; however, low awareness and poor com-
mitment to following the national guidelines were probable
reasons. Harries et al. [10] reported that improved adherence
to existing guidelines for diagnosis and treatment could go a
long way in improving TB care and outcome. Contrary to the
national guidelines, most of the patientswere diagnosedwith-
out two smear negative results, and less than half of them
received antibiotics trial despite having a chest radiograph
done. Primary healthcare facilities most times do not have
radiology services, so patients requiring such services are
often referred to higher levels of healthcare. However, access
to such services may be limited by distance and cost and
may account for a delay in diagnosis of smear negative PTB.
In Nigeria, a weak referral system and support constitute a
major weakness in the country’s healthcare system [11,12].
Chest radiograph findings – though they may not be specific
– still constitute an important tool in the diagnosis of sputum
smear negative PTB. Higher healthcare facilities were more
likely to prescribe antibiotics in themanagement of suspected
smear-negative PTB cases. Consequently, the interval in the
completion of antibiotics might have accounted for the delay
in initiating treatment seen in tertiary healthcare facilities.
Forty-five per cent of the patients treated were HIV posi-
tive. Thus, this study also compared steps taken to manage
smear negative PTB from diagnosis until commencement of
treatment between HIV positive and HIV negative individuals,
but did not assess treatment outcome. It is evident from the
study that patients were subjected to the same diagnostic
protocol irrespective of their HIV sero-status. Sadly, the HIV-
positive individuals were more likely to have commenced
anti-TB treatment later compared with the HIV negative indi-
viduals. The advent of HIV has resulted in a number of coun-
tries revising their algorithm for management of smear
negative TB in line with WHO recommendations so as to
reduce time taken to diagnose TB in HIV-positive individuals,
address challenges of atypical presentation of TB associated
with HIV disease and the need to exclude other opportunistic
diseases that present like TB. Revision of the guideline
became necessary to improve case detection, reduce the bur-
den of co-morbidity and reduce the mortality associated withboth illnesses, as HIV-positive patients suffering from TB are
more likely to deteriorate faster and die [4–6].
In conclusion, this study highlights the need to carry out
further studies to identify factors responsible for non-adher-
ence to the national TB guidelines in the diagnosis of sputum
smear negative PTB. The implication of the study is that
assessment of adherence to TB management protocol or
guideline is a measure of quality assurance, hence a measure
of performance of the National TB Control Program. Also, in
line with the recommendation of Harries et al. [10], there is
a need to validate the current guidelines in line with the cur-
rent realities, particularly the HIV epidemic which has altered
the previously known parameters of the management of
smear negative pulmonary TB.
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